|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06108 NEW RAY MEDIC
Nominal 
0.000 (0.000%) | 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 16,718 | -46.099% | 50,154 | 89,771 | 335,380 | 133,214 |
| Cost of Sales | (10,492) | -56.016% | (37,213) | (76,523) | (306,892) | (122,283) |
| Gross Profit | 6,226 | -13.069% | 12,941 | 13,248 | 28,488 | 10,931 |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (267) | -- | 423 | -- | -- | (37,325) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 1,110 | 1,484 | |
| Profit / (Loss) before Taxation | (4,083) | -69.432% | (22,342) | (80,286) | (3,608) | (69,901) | |
| Taxation | (5) | -- | 172 | 2,339 | 784 | 170 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (4,088) | -69.394% | (22,170) | (77,947) | (2,824) | (69,731) | |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | (1,312) | -9.455% | (2,936) | (2,715) | (931) | (1,477) |
| Depreciation & Amortisation | 3,252 | -32.921% | 9,767 | 10,173 | 9,603 | 9,336 |
| Directors' Emoluments | -- | -- | 3,080 | 5,053 | 2,923 | 3,425 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Qualified | Qualified | Qualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -0.240 | -70.000% | -1.330 | -4.660 | -0.170 | -4.170 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.027) | 0.000 | (0.035) | (0.019) |
| NBV per share ($) | 0.280 | -- | 0.287 | 0.314 | 0.378 | 0.362 |
| Remarks: | Real time quote last updated: 26/11/2024 07:42 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -4,088,000 |
| %Change | -69.394% |
| EPS / (LPS) | HKD -0.002 |
| NBV Per Share ($) | HKD 0.280 |